A conversation with Recordati’s Dr. Mario Maldonado

Today’s podcast features my chat with Dr. Mario Maldonado, Head of Development and Global Endocrinology at Recordati Rare Diseases.  Dr. Maldonado brings a wealth of experience and a great perspective on drug development. He was involved in developing both pasireotide and osilodrostat, two essential compounds used in drugs to treat Cushing’s.   Listen to this fascinating talk with one of the most dynamic experts in endocrine drug development today. He talks about endocrinology, the science of cortisol production, the art and science of endocrine medicine, and the opportunities for new drugs and therapies in the US and Europe.  We also focused on the findings from a Recordati new study, LINC-7,  – read more about the study here –  potentially leading to new indications (uses) for osilodrostat (Isturisa®).

Click here for more information and content on Cushing’s and hypercortisolism from Pituitary World News.

Order Dr. Lewis Blevins new book Cushing’s; a comprehensive guide to understanding a devastating disease.  Click here to buy your copy today







Image by Satheesh Sankaran from Pixabay

© 2024, Pituitary World News. All rights reserved.